FDAnews Device Daily Bulletin

BOSTON SCIENTIFIC SAYS STENT HAS AN EDGE ON J&J

Nov. 29, 2005
A A

Boston Scientific said a study it commissioned shows that its Taxus Express cardiac stent has an edge over Johnson & Johnson's rival product, according to the Wall Street Journal's online edition on Sunday. The study found "substantial differences" between Taxus and J&J's Cypher in the categories of death, serious injury, reclogging of the arteries, or restenosis, and blood-clotting, or thrombosis, Boston Scientific spokesman Paul Donovan said.

Reuters (http://today.reuters.com/investing/financeArticle.aspx?type=marketsNews&storyID=2005-11-27T203818Z_01_N27666657_RTRIDST_0_HEALTH-BOSTONSCIENTIFIC.XML)